FDA Import Refusal 799-8718605-2/11/1 — Glaxosmithkline Argentina S.A.
The FDA refused shipment 799-8718605-2/11/1 from Glaxosmithkline Argentina S.A. (Argentina) on Jun 1, 2022. The refused product falls under Drugs and Biologics — DICLOFENAC SODIUM (ANTI-INFLAMMATORY). Cited charges: 118,472,75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Jun 1, 2022
- Country
- Argentina
- Product Category
- Drugs and Biologics
- Product Code
- 62GDJ18 DICLOFENAC SODIUM (ANTI-INFLAMMATORY)
- Charges
- 118,472,75